Would you like to host a complimentary Grand Rounds presentation for your Community oncologists and their interprofessional care team of nurse practitioners, nurses, pharmacists, and physician assistants who manage patients with triple-negative breast cancer (TNBC).
Sara M. Tolaney, MD, MPH
Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute
Associate Director of the Susan F. Smith Center for Women’s Cancers
Senior Physician at Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
5 min - Welcome and Introductions
15 min - Delineating the Disparity in TNBC: The Interface of Disease State Complexity and Social Inequity
20 min - Demystifying Antibody-Drug Conjugates: Practical Approaches to Embracing Change in the Evolving TNBC Paradigm
15 min - Closing the TNBC Outcomes Chasm: Case-based Challenges for the Community Oncologist and Their Interprofessional Team
5 min - Conclusion and Q&A
- Discuss the multifaceted etiology of the racial disparity observed in triple-negative breast cancer (TNBC), with a focus on both biologic and non-biologic factors, and identify tangible strategies community-based clinicians can employ to promote equitable care and outcomes for all patients.
- Review antibody-drug conjugate (ADC) structure, mechanism of action, and real-world clinical considerations, including dosing, administration, and toxicity management, for community oncology clinicians using ADCs to manage TNBC.
- Examine completed, ongoing, and planned clinical trial data for ADCs as part of the evolving and expanding TNBC treatment calculus, including recent FDA approvals and updated guideline recommendations.
- Using a patient case-driven approach, design evidence-based treatment plans for patients with TNBC, with an emphasis on the placement of novel therapies in the shifting TNBC treatment calculus and the effective integration of socioeconomic and other non-biologic factors into equitable cancer care.
In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1 hour of Interprofessional Continuing Education (IPCE) credit for learning and change.
CEC designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This application-based activity is approved for 1.0 contact hour (.10 CEUs) of continuing pharmacy education credit (JA0007101-0000-21-001-L01-P)
This activity is designated for 1.0 contact hour.
Upon completion of a CE request form, statements of credit for physicians, physician assistants, and nurses will be issued within 30 business days. Pharmacy credit will be reported directly to the National Association of Boards of Pharmacy® (NABP®) CPE Monitor electronic CE tracking system.